Literature DB >> 4126332

Effect of treatment with nicotinic acid for one month on serum lipids in patients with different types of hyperlipidemia.

L A Carlson, L Orö.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4126332     DOI: 10.1016/0021-9150(73)90113-5

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


× No keyword cloud information.
  7 in total

Review 1.  Indications for lipid-lowering drugs.

Authors:  J Davignon
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

Review 2.  Hypolipaemic drugs and coronary heart disease.

Authors:  A N Howard
Journal:  J Clin Pathol Suppl (R Coll Pathol)       Date:  1975

3.  [Drug treatment of primary hyperlipoproteinemia (author's transl)].

Authors:  G Klose; R Mordasini; G Middelhoff; J Augustin; H Greten
Journal:  Klin Wochenschr       Date:  1978-02-01

4.  [Relation between serum lipoprotein metabolism and biliary lipid metabolism].

Authors:  O Leiss; K von Bergmann
Journal:  Klin Wochenschr       Date:  1983-06-15

Review 5.  Combination drug therapy for combined hyperlipidemia.

Authors:  J R Guyton
Journal:  Curr Cardiol Rep       Date:  1999-09       Impact factor: 3.955

6.  The APOE3-Leiden Heterozygous Glucokinase Knockout Mouse as Novel Translational Disease Model for Type 2 Diabetes, Dyslipidemia, and Diabetic Atherosclerosis.

Authors:  Marianne G Pouwer; Suvi E Heinonen; Margareta Behrendt; Anne-Christine Andréasson; Arianne van Koppen; Aswin L Menke; Elsbet J Pieterman; Anita M van den Hoek; J Wouter Jukema; Brendan Leighton; Ann-Cathrine Jönsson-Rylander; Hans M G Princen
Journal:  J Diabetes Res       Date:  2019-02-21       Impact factor: 4.011

7.  Niacin Reduces Atherosclerosis Development in APOE*3Leiden.CETP Mice Mainly by Reducing NonHDL-Cholesterol.

Authors:  Susan Kühnast; Mieke C Louwe; Mattijs M Heemskerk; Elsbet J Pieterman; Jan B van Klinken; Sjoerd A A van den Berg; Johannes W A Smit; Louis M Havekes; Patrick C N Rensen; José W A van der Hoorn; Hans M G Princen; J Wouter Jukema
Journal:  PLoS One       Date:  2013-06-19       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.